Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

If you have high blood pressure that seems resistant to treatment, sleep apnea might be an underlying cause. If you recognize multiple signs from this list, it’s crucial to consult a healthcare ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Sleep apnea involves repeated breathing interruptions during sleep, while loud snoring is steady and doesn’t typically affect breathing. A doctor can help confirm the difference. Sleep apnea is ...

“Identifying additional modifiable risk factors would add to current clinical risk mitigation strategies ... Participants were excluded if they had been or were being treated for sleep apnea. All ...

Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for a Phase 2 clinical trial ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.

Researchers combine OCT imaging and computational fluid dynamics to accurately map upper airway obstructions, advancing sleep apnea diagnosis and treatment.

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...